We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+4.32%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$7.37B
AUM Growth
+$1.05B
Cap. Flow
+$903M
Cap. Flow %
12.26%
Top 10 Hldgs %
61.73%
Holding
164
New
32
Increased
76
Reduced
24
Closed
32

Sector Composition

Rank Sector Weight
1 Technology 26.49%
2 Healthcare 19.14%
3 Industrials 16.44%
4 Communication Services 11.2%
5 Consumer Staples 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
51
AbbVie
ABBV
$468B
$3.13M 0.04%
50,540
+7,370
+17% +$449K
LLTC
52
DELISTED
Linear Technology Corp
LLTC
$3.13M 0.04%
+67,220
New +$3.07M
FTI icon
53
TechnipFMC
FTI
$30.4B
$3.12M 0.04%
+157,006
New +$3.25M
WSM icon
54
Williams-Sonoma
WSM
$28B
$3.12M 0.04%
119,540
+31,480
+36% +$863K
IPG
55
DELISTED
Interpublic Group of Companies
IPG
$3.08M 0.04%
133,570
+23,360
+21% +$549K
PPG icon
56
PPG Industries
PPG
$25.3B
$3.08M 0.04%
+29,540
New +$3.23M
LDOS icon
57
Leidos
LDOS
$17.7B
$3.06M 0.04%
+63,980
New +$3.16M
VLO icon
58
Valero Energy
VLO
$100B
$3.05M 0.04%
59,730
+21,540
+56% +$1.22M
CTSH icon
59
Cognizant
CTSH
$27.9B
$3.02M 0.04%
52,830
+12,580
+31% +$760K
KATE
60
DELISTED
Kate Spade & Company
KATE
$3M 0.04%
+145,530
New +$3.32M
MSM icon
61
MSC Industrial Direct
MSM
$6.69B
$2.98M 0.04%
+42,170
New +$3.13M
PBF icon
62
PBF Energy
PBF
$8.72B
$2.92M 0.04%
122,690
+46,720
+61% +$1.34M
CPS icon
63
Cooper-Standard Automotive
CPS
$498M
$2.91M 0.04%
+36,829
New +$2.97M
SFM icon
64
Sprouts Farmers Market
SFM
$7.56B
$2.9M 0.04%
+126,660
New +$3.24M
MYGN icon
65
Myriad Genetics
MYGN
$306M
$2.87M 0.04%
+93,870
New +$3.26M
ANF icon
66
Abercrombie & Fitch
ANF
$4.84B
$2.85M 0.04%
+159,930
New +$3.81M
NXST icon
67
Nexstar Media Group
NXST
$5.73B
$2.84M 0.04%
59,770
+5,560
+10% +$278K
UTHR icon
68
United Therapeutics
UTHR
$22B
$2.83M 0.04%
26,710
+5,780
+28% +$645K
STRZA
69
DELISTED
Starz - Series A
STRZA
$2.82M 0.04%
94,370
+25,860
+38% +$688K
WBMD
70
DELISTED
WebMD Health Corp.
WBMD
$2.81M 0.04%
48,370
+7,410
+18% +$463K
LEA icon
71
Lear
LEA
$8.56B
$2.81M 0.04%
27,600
+4,960
+22% +$558K
NAVI icon
72
Navient
NAVI
$886M
$2.77M 0.04%
232,030
+18,300
+9% +$233K
INTC icon
73
Intel
INTC
$476B
$2.72M 0.04%
82,840
+25,970
+46% +$814K
SBUX icon
74
Starbucks
SBUX
$122B
$2.7M 0.04%
47,320
+16,840
+55% +$958K
TXN icon
75
Texas Instruments
TXN
$241B
$2.69M 0.04%
43,000
+11,250
+35% +$669K

Similar funds

Lee Ainslie's Q2 2016 Portfolio in Review

As of Q2 2016, Lee Ainslie held 164 positions worth $7.37B, up 17% from $6.32B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Lee Ainslie deployed $903M of net new capital in Q2 2016, opening 32 new positions and adding to 76 existing holdings. Its largest new stake was Philip Morris: 5,851,537 shares worth $595M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Liberty Global Class C, an estimated $213M trimmed.

  • Lee Ainslie's largest Q2 2016 buy was Philip Morris: 5,851,537 shares worth $595M.
  • Lee Ainslie added most to Pfizer in Q2 2016, an estimated $343M increase.
  • Lee Ainslie's biggest Q2 2016 reduction was Liberty Global Class C, cutting an estimated $213M.
  • Lee Ainslie fully exited Sensata Technologies in Q2 2016, selling an estimated $137M.
  • Lee Ainslie's ten largest holdings make up 62% of its $7.37B portfolio in Q2 2016.
  • Lee Ainslie opened 32 new positions and closed 32 in Q2 2016.
  • Lee Ainslie's portfolio value rose 17% quarter-over-quarter to $7.37B.

Based on Maverick Capital's 13F filing for Q2 2016, filed 15 Aug 2016.